Heparin Shortages Due to a Dependence on China. Why American Cattle is the Solution.
By Kenneth Rapoza, CPA Industry Analyst Why are we dependent on China’s pig population for a critical animal source material used in making heparin? Bovine
The U.S. needs to support American-made medicines
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
Industry Analysis: Securing USA Made PPE Before the Next Health Crisis
By Kenneth Rapoza, CPA Industry Analyst Summary: If we experience a global pandemic like this again, we know two things to be true: we can’t
Reshoring Pharmaceutical Production: Are Buy America Laws Enough?
By Kenneth Rapoza, Industry Analyst, CPA President Trump and many members of Congress are talking about reshoring pharmaceutical production. We look at the benefits of
Domestic Drug Producers Score A Win With Executive Order
By Ken Rapoza, CPA Industry Analyst Major pharmaceutical importers have pushed back against the White House’s proposal to support domestic labs. But on Thursday, American
Interview: ‘China RX’ Author Rosemary Gibson Sounds Alarm Over Chinese-Made Medicine
Editor’s note: Rosemary Gibson is a CPA member. Rosemary Gibson is a senior advisor at the Hastings Center, a bioethics research institute, and is the
The Biden Plan to Rebuild U.S. Supply Chains and Ensure the U.S. Does Not Face Future Shortages of Critical Equipment
Editor’s note: The Biden campaign released a plan to rebuild domestic manufacturing. There is recognition that we need to focus upon critical supply chains. However,
Over 1,300 Chinese Medical Suppliers to U.S.—Including Mask Providers—Use Bogus Registration Data
Editor’s note: Chinese companies’ fraud is not just in the stock market, it is in the FDA approval database. WSJ analysis shows gaps in FDA
FDA Misled Senators on China’s Role as Vital U.S. Drug Supplier
Editor’s note: FDA is complicit in offshoring our drug supply chain. We need to bring it back to the US. The Food and Drug Administration
The Fight To Reshore US Pharmaceuticals
Editor’s Note: Michael Stumo is CEO of the Coalition for a Prosperous America. Follow him at @michael_stumo The coronavirus pandemic has revealed a troubling truth: Global
